Redox, a Madison, WI-based company that is changing the way healthcare providers and software vendors share data has raised $33 million in Series C funding led by Battery Ventures. The Series C round also included participation from existing investors .406 Ventures, RRE Ventures, and Intermountain Ventures.
Finally. A Scalable Way to Exchange Healthcare Data
Currently, inconsistent data formats and redundant connections slow, or completely prevent the flow of critical health information, hindering patient care. Founded in 2014 by former Epic Systems employees engineers, Redox changes this by dramatically simplifying communication, making data actionable and more shareable.
Transform Legacy EHR Interfaces Into A Suite of Reusable APIs
With Redox’s interoperability platform, software developers enable easy access through an intuitive and standardized application programming interface (API). Redox’s vendor-agnostic approach allows messages to be sent or received securely in any format associated with an organizations electronic health record (EHR).
As a result, Redox’s technology powers a streamlined workflow for caregivers, improving care delivery and the patient experience. Clinicians can use a variety of targeted apps and technology to meet their needs, instead of a one-size-fits-all approach. Healthcare providers can cut their integration times by two-thirds from an average of 100 days to 30 days with Redox.
Recent Traction/Milestones
To date, over 450 healthcare providers and hundreds of cloud-based applications use the Redox Interoperability Platform to easily exchange information with partners. Key clients include AdventHealth, Atrium Health, Brigham & Women’s, Clarify Health, Cleveland Clinic, Geisinger, HCA, Healthgrades, Intermountain Healthcare, Invitae, Fitbit, Memorial Sloan Kettering, Microsoft, Ochsner, OSF HealthCare, PointClickCare, R1, ResMed, Stryker, UCSF, University of Pennsylvania, and WellStar.
In addition to its numerous customer wins and strategic partnerships, Redox was selected by Gartner as a 2018 Cool Vendor for the company’s innovative, high-impact, and pioneering work. This recognition highlights the company’s unique approach to interoperability through a networked model utilizing a strictly enforced, consistent data model.
“Redox’s success is built on the success of our customers, the most innovative software solutions and healthcare organizations in the market today,” said co-founder and CEO Luke Bonney. “We have a saying at Redox: ‘We are all patients.’ This informs our perspective about what we do as we build the infrastructure our customers rely on every day. We’re grateful to be in a position to help solve one of healthcare’s thorniest challenges.”
